Alerta Mobile Cushion System, Battery-Powered Alternating Pressure Relief for High-Risk Users
- Battery-powered alternating pressure cushion providing high-risk pressure care without mains power dependency, with a lithium-ion battery delivering more than 24 hours of operation in static mode and a full day of use in alternating (dynamic) mode - enabling continuous alternating pressure treatment in wheelchair-using patients who cannot be restricted to mains-adjacent seating, in vehicle transport, and in community and home care settings without accessible power outlets.
- Lithium-ion battery eliminates the trailing power cable that mains-powered alternating pressure cushion systems require between the wheelchair, chair or seating system and the nearest power outlet - a cable that creates trip hazards for carers and mobility obstacles for the patient and is a practical barrier to alternating pressure use in dynamic community care settings where mains-powered systems are impractical.
- TPU-coated independently removable cells with multi-stretch, vapour-permeable, antimicrobial PU cover and enclosed zipper provide the same cell durability, targeted maintenance capability and microclimate management as the mains-powered Partner system, delivering full NICE CG179 clinical specification in a portable format without compromising the pressure care performance for high-risk users in mobile settings.
- Clinical pressure mapping evaluation with simple settings for carer operation, enabling the system to be set to optimal pressure for the individual patient by care staff without specialist equipment training, and supporting the documented individual pressure care plan that CQC Regulation 12 (Safe Care and Treatment) requires for patients assessed as high risk.
Alerta Mobile Cushion System: Battery-Powered Alternating Pressure Cushion for High-Risk Users in Mobile Care Settings
The Alerta Mobile Cushion System is a battery-powered alternating pressure cushion for high-risk patients who require dynamic seated pressure care but cannot be restricted to mains-adjacent seating positions. The lithium-ion battery provides more than 24 hours of static mode operation and a full day of alternating (dynamic) mode use, enabling continuous alternating pressure treatment in wheelchair users across community care settings, vehicle transport and home environments where mains-powered systems are impractical. TPU-coated independently removable cells, multi-stretch vapour-permeable antimicrobial PU cover and enclosed zipper provide the clinical performance of the mains Partner system in a cable-free portable format. Clinical pressure mapping evaluation included.
Product Specifications
| Specification | Detail |
|---|---|
| Product Code | NCL-ALT-215/04 |
| Type | Battery-powered alternating pressure cushion |
| Risk Level | High risk (Waterlow 20+) |
| Battery | Lithium-ion |
| Battery Life (Static) | More than 24 hours |
| Battery Life (Alternating) | Full day of dynamic use |
| Cells | TPU-coated, independently removable |
| Cover | Enclosed zipper, multi-stretch vapour-permeable PU |
| Cover Cleaning | Antimicrobial, machine washable |
| Pressure Mapping | Clinical pressure mapping evaluation included |
Clinical and Regulatory Compliance
NICE Guideline CG179 (Pressure Ulcers: Prevention and Management) recommends that patients at high risk of pressure ulcers who are wheelchair users or spend extended periods seated receive an appropriate pressure-relieving cushion, and that the cushion specification is matched to both the patient's risk level and their use environment. For community-based, wheelchair-using patients, mains-powered alternating pressure systems are frequently impractical - the Mobile Cushion System resolves this by providing full alternating pressure performance without mains dependency, extending NICE CG179-compliant care to settings where it was previously not achievable with powered alternating pressure equipment. CQC Regulation 12 (Safe Care and Treatment) applies to community care providers as well as residential settings: for community care packages that include pressure care management for high-risk patients, the battery-powered alternating pressure system enables the care provider to document alternating pressure in the patient's care plan with confidence that the equipment will function across the full range of the patient's daily activities and environments.
Frequently Asked Questions
How is the battery recharged, and can the cushion still be used while charging?
The lithium-ion battery is recharged by connecting the pump unit to a mains power source when the patient is in a location with mains access - typically overnight in the home or care setting. Whether the cushion continues to provide alternating pressure during charging, or whether charging requires the system to be in static or off mode, depends on the specific pump unit configuration: confirm the charging protocol from the product documentation supplied with the unit. For patients who require continuous alternating pressure, the battery's more-than-24-hour static mode duration means the cushion remains functional for more than a full day between charges in static mode, with the alternating mode providing a full day of dynamic use before recharging is required. Battery replacement and recycling should follow the care home's or organisation's lithium-ion battery management policy.
Is the Alerta Mobile Cushion System suitable for vehicle transport, and are there safety considerations for use in vehicles?
The Alerta Mobile Cushion System's battery-powered operation makes it practically compatible with vehicle use, as no mains connection is required during transport. However, the clinical suitability of continuing alternating pressure treatment during vehicle transport depends on the individual patient's clinical assessment: in some cases, the transport mode (static pressure) may be more appropriate for vehicle use, particularly in vehicles where the seating position may change or where vibration during transport could affect cushion stability. Whether the cushion is used in alternating or static mode during vehicle transport should be specified in the individual's pressure care plan by the prescribing clinician. Vehicular wheelchair seating safety standards require that wheelchair cushions used in vehicles comply with relevant crash-test standards where applicable - confirm vehicular use compliance with the supplier if the cushion will be used in a wheelchair secured in a vehicle.
NCL-ALT-215/04
13 other products in the same category:
- Battery-powered alternating pressure cushion providing high-risk pressure care without mains power dependency, with a lithium-ion battery delivering more than 24 hours of operation in static mode and a full day of use in alternating (dynamic) mode - enabling continuous alternating pressure treatment in wheelchair-using patients who cannot be restricted to mains-adjacent seating, in vehicle transport, and in community and home care settings without accessible power outlets.
- Lithium-ion battery eliminates the trailing power cable that mains-powered alternating pressure cushion systems require between the wheelchair, chair or seating system and the nearest power outlet - a cable that creates trip hazards for carers and mobility obstacles for the patient and is a practical barrier to alternating pressure use in dynamic community care settings where mains-powered systems are impractical.
- TPU-coated independently removable cells with multi-stretch, vapour-permeable, antimicrobial PU cover and enclosed zipper provide the same cell durability, targeted maintenance capability and microclimate management as the mains-powered Partner system, delivering full NICE CG179 clinical specification in a portable format without compromising the pressure care performance for high-risk users in mobile settings.
- Clinical pressure mapping evaluation with simple settings for carer operation, enabling the system to be set to optimal pressure for the individual patient by care staff without specialist equipment training, and supporting the documented individual pressure care plan that CQC Regulation 12 (Safe Care and Treatment) requires for patients assessed as high risk.